Dec 11, 2024

Featuring perspectives from Dr Heather Wakelee, including the following topics:

• Introduction (0:00)
• Cases: A man in his late 50s with metastatic carcinoma of the lung, no actionable genomic alteration (AGA), PD-L1-negative, and a man in his early 60s with metastatic squamous cell carcinoma of the lung, PD-L1-negative...

Dec 5, 2024

Featuring perspectives from Dr Priyanka Sharma and Dr Sara M Tolaney, including the following topics:

• Introduction: Metastatic Triple-Negative Breast Cancer (mTNBC) — The Patient Perspective (0:00)
• Selection and Sequencing of Antibody-Drug Conjugates (5:09)
• Dosing and Tolerability of Sacituzumab Govitecan; Use of...

Dec 4, 2024

Featuring perspectives from Dr Gloria Gerber, Dr Jamie Koprivnikar, Prof Alexander Röth and Dr Jamile M Shammo, including the following topics:

Introduction: Paroxysmal Nocturnal Hemoglobinuria (PNH) and the General Medical Oncologist

• Diagnosis of and myths and misperceptions about PNH (0:00)

Overview — Biology and...

Dec 4, 2024

Practical Perspectives: Investigators Discuss the Current Management of Paroxysmal Nocturnal Hemoglobinuria — Jamile M Shammo, MD

CME information and select publications

Nov 26, 2024

Featuring an interview with Dr Seth Wander, including the following topics:

• ASCO Guidelines Rapid Recommendations Update for Testing for ESR1 Mutations (0:00)
• Real-world elacestrant use patterns and genomic biomarkers (4:43)
• Circulating tumor DNA (ctDNA) analyses with imlunestrant in the EMBER Phase I study (8:50)